Keith Larson 10b5-1 Sales Listed for VG (NYSE: VG)

Rhea-AI Filing Summary

VG (Form 144) notice reports proposed and completed insider sales of Common Stock by a reporting party. The excerpt lists multiple 10b5-1 sales by Keith Larson on 03/18/2026, 03/19/2026, 04/15/2026, and 04/16/2026 with share counts and dollar amounts shown. The filing also references an Exercise of Stock Options on 05/14/2026.

Insights

Insider Transactions Analyst

Filed notice lists multiple planned and executed 10b5-1 sales by a single reporting person.

The excerpt shows discrete executed 10b5-1 sales by Keith Larson on 03/18/2026 (1,793,862 shares, $26,936,990.56) and 03/19/2026 (3,206,138 shares, $49,853,842.83), plus two sales in April 2026 totaling 1,111,112 shares and approximately $13,895,733.34. These are reported share dispositions under an established trading plan.

Timing and cash‑flow treatment are explicit for each row (sales proceeds shown). Subsequent filings or broker confirmations would show final settlement; the excerpt documents executed sales and a separate Exercise of Stock Options dated 05/14/2026.

Corporate Governance Specialist

The filing documents compliance actions (10b5-1 sales and an option exercise) rather than strategic corporate changes.

The entries identify the method (10b5-1), reporting party name and addresses, share counts, and gross proceeds for each sale. The record format aligns with routine insider-sale disclosures under resale notice requirements.

Material impact depends on holdings and outstanding share base, which are not provided in the excerpt; investor‑relevant context may appear in other company filings.

Key Figures

Sale on 03/19/2026: 3,206,138 shares Proceeds on 03/19/2026: $49,853,842.83 Sale on 03/18/2026: 1,793,862 shares +4 more

7 metrics

Sale on 03/19/2026 3,206,138 shares 10b5-1 sale, <date>03/19/2026</date>

Proceeds on 03/19/2026 <money>$49,853,842.83</money> Gross proceeds shown for 3,206,138 shares

Sale on 03/18/2026 1,793,862 shares 10b5-1 sale, <date>03/18/2026</date>

Proceeds on 03/18/2026 <money>$26,936,990.56</money> Gross proceeds shown for 1,793,862 shares

Sales on 04/15–04/16/2026 555,556 shares each date 10b5-1 sales on <date>04/15/2026</date> and <date>04/16/2026</date>

Proceeds in April 2026 <money>$6,875,505.50</money> and <money>$7,020,227.84</money> Gross proceeds for 04/15/2026 and 04/16/2026 sales

Option exercise date 05/14/2026 Exercise of Stock Options listed under Securities To Be Sold

Key Terms

10b5-1, Exercise of Stock Options, Securities To Be Sold

3 terms

10b5-1 regulatory

"10b5-1 Sales for KEITH LARSON 1001 19th Street North..."

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 05/14/2026 | Exercise of Stock Options | Issuer"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 05/14/2026 | Exercise of Stock Options"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1111111	14444443.00	515753572	05/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/14/2026	Exercise of Stock Options	Issuer			1111111	05/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KEITH LARSON 1001 19th Street North, Suite 1500 Arlington VA 22209	Common	04/16/2026	555556	7020227.84
10b5-1 Sales for KEITH LARSON 1001 19th Street North, Suite 1500 Arlington VA 22209	Common	04/15/2026	555556	6875505.50
10b5-1 Sales for KEITH LARSON 1001 19th Street North, Suite 1500 Arlington VA 22209	Common	03/19/2026	3206138	49853842.83
10b5-1 Sales for KEITH LARSON 1001 19th Street North, Suite 1500 Arlington VA 22209	Common	03/18/2026	1793862	26936990.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What 10b5-1 sales does VG's Form 144 report for Keith Larson?

The filing lists executed 10b5-1 sales on 03/18/2026 (1,793,862 shares, $26,936,990.56), 03/19/2026 (3,206,138 shares, $49,853,842.83), 04/15/2026 (555,556 shares, $6,875,505.50), and 04/16/2026 (555,556 shares, $7,020,227.84).

Does the excerpt show an option exercise for VG and when?

Yes. The excerpt references an Exercise of Stock Options dated 05/14/2026 listed under "Securities To Be Sold." The filing entry ties the exercise to the issuer and notes cash as the consideration method.

Are the proceeds from the sales disclosed in the Form 144 excerpt?

Yes. Each sale row includes gross proceeds: for example, $49,853,842.83 for 3,206,138 shares on 03/19/2026 and $26,936,990.56 for 1,793,862 shares on 03/18/2026, with additional April 2026 amounts listed.

Do these entries indicate transactions were under a trading plan?

The excerpt explicitly labels the sales as 10b5-1 Sales, indicating they were executed under a prearranged trading plan. The filing names the reporting person as Keith Larson and provides addresses for each sale entry.

Does the filing state how these sales affect shares outstanding or dilution for VG?

The provided excerpt does not include shares outstanding or dilution metrics. It lists the sold share counts and proceeds, but baseline outstanding shares are not present in the excerpt.